These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 17374885)
1. Evaluation of T-cell responses to peptides with MHC class I-binding motifs derived from PE_PGRS 33 protein of Mycobacterium tuberculosis. Chaitra MG; Shaila MS; Nayak R J Med Microbiol; 2007 Apr; 56(Pt 4):466-474. PubMed ID: 17374885 [TBL] [Abstract][Full Text] [Related]
2. Characterization of T-cell immunogenicity of two PE/PPE proteins of Mycobacterium tuberculosis. Chaitra MG; Shaila MS; Nayak R J Med Microbiol; 2008 Sep; 57(Pt 9):1079-1086. PubMed ID: 18719176 [TBL] [Abstract][Full Text] [Related]
3. A comparative study of host response to three Mycobacterium tuberculosis PE_PGRS proteins. Singh PP; Parra M; Cadieux N; Brennan MJ Microbiology (Reading); 2008 Nov; 154(Pt 11):3469-3479. PubMed ID: 18957600 [TBL] [Abstract][Full Text] [Related]
4. RD5-mediated lack of PE_PGRS and PPE-MPTR export in BCG vaccine strains results in strong reduction of antigenic repertoire but little impact on protection. Ates LS; Sayes F; Frigui W; Ummels R; Damen MPM; Bottai D; Behr MA; van Heijst JWJ; Bitter W; Majlessi L; Brosch R PLoS Pathog; 2018 Jun; 14(6):e1007139. PubMed ID: 29912964 [TBL] [Abstract][Full Text] [Related]
5. Identification of murine H2-Dd- and H2-Ab-restricted T-cell epitopes on a novel protective antigen, MPT51, of Mycobacterium tuberculosis. Suzuki M; Aoshi T; Nagata T; Koide Y Infect Immun; 2004 Jul; 72(7):3829-37. PubMed ID: 15213124 [TBL] [Abstract][Full Text] [Related]
6. Induction of in vivo functional Db-restricted cytolytic T cell activity against a putative phosphate transport receptor of Mycobacterium tuberculosis. Romano M; Denis O; D'Souza S; Wang XM; Ottenhoff TH; Brulet JM; Huygen K J Immunol; 2004 Jun; 172(11):6913-21. PubMed ID: 15153510 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of T-cell responses to peptides and lipopeptides with MHC class I binding motifs derived from the amino acid sequence of the 19-kDa lipoprotein of Mycobacterium tuberculosis. Fonseca DP; Joosten D; Snippe H; Verheul AF Mol Immunol; 2000 Jun; 37(8):413-22. PubMed ID: 11090876 [TBL] [Abstract][Full Text] [Related]
8. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant. Chaitra MG; Nayak R; Shaila MS Vaccine; 2007 Oct; 25(41):7168-76. PubMed ID: 17709160 [TBL] [Abstract][Full Text] [Related]
9. Comparative immune response to PE and PE_PGRS antigens of Mycobacterium tuberculosis. Delogu G; Brennan MJ Infect Immun; 2001 Sep; 69(9):5606-11. PubMed ID: 11500435 [TBL] [Abstract][Full Text] [Related]
10. Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides. Wang M; Tang ST; Stryhn A; Justesen S; Larsen MV; Dziegiel MH; Lewinsohn DM; Buus S; Lund O; Claesson MH Immunology; 2011 Apr; 132(4):482-91. PubMed ID: 21294723 [TBL] [Abstract][Full Text] [Related]
11. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Radosevic K; Wieland CW; Rodriguez A; Weverling GJ; Mintardjo R; Gillissen G; Vogels R; Skeiky YA; Hone DM; Sadoff JC; van der Poll T; Havenga M; Goudsmit J Infect Immun; 2007 Aug; 75(8):4105-15. PubMed ID: 17526747 [TBL] [Abstract][Full Text] [Related]
12. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice. Kim A; Hur YG; Gu S; Cho SN Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of late stage specific peptide antigens of Mycobacterium tuberculosis. Singh M; Bhatt P; Sharma M; Varma-Basil M; Chaudhry A; Sharma S Infect Genet Evol; 2019 Oct; 74():103930. PubMed ID: 31228643 [TBL] [Abstract][Full Text] [Related]
14. Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential. Chaitra MG; Hariharaputran S; Chandra NR; Shaila MS; Nayak R Vaccine; 2005 Jan; 23(10):1265-72. PubMed ID: 15652669 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3. Romano M; Roupie V; Wang XM; Denis O; Jurion F; Adnet PY; Laali R; Huygen K Immunology; 2006 Jul; 118(3):321-32. PubMed ID: 16827893 [TBL] [Abstract][Full Text] [Related]
16. HLA-A*0201-restricted cytotoxic T-cell epitopes in three PE/PPE family proteins of Mycobacterium tuberculosis. Chaitra MG; Shaila MS; Chandra NR; Nayak R Scand J Immunol; 2008 Apr; 67(4):411-7. PubMed ID: 18248530 [TBL] [Abstract][Full Text] [Related]
17. Specific immune responses induced by multi-epitope DNA derived from Mycobacterium tuberculosis DosR antigens. Moradi J; Izad M; Tabrizi M; Mosavari N; Esmaeili B; Feizabadi MM Acta Microbiol Immunol Hung; 2018 Jun; 65(2):193-209. PubMed ID: 29552899 [TBL] [Abstract][Full Text] [Related]
18. Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70. Al-Attiyah R; Shaban FA; Wiker HG; Oftung F; Mustafa AS Infect Immun; 2003 Apr; 71(4):1953-60. PubMed ID: 12654813 [TBL] [Abstract][Full Text] [Related]
19. Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Denis O; Tanghe A; Palfliet K; Jurion F; van den Berg TP; Vanonckelen A; Ooms J; Saman E; Ulmer JB; Content J; Huygen K Infect Immun; 1998 Apr; 66(4):1527-33. PubMed ID: 9529077 [TBL] [Abstract][Full Text] [Related]
20. Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity. Joosten SA; van Meijgaarden KE; van Weeren PC; Kazi F; Geluk A; Savage ND; Drijfhout JW; Flower DR; Hanekom WA; Klein MR; Ottenhoff TH PLoS Pathog; 2010 Feb; 6(2):e1000782. PubMed ID: 20195504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]